The first Edwards Lifesciences trade was made in Q1 2001.
Since then Mario Gabelli bought shares 21 more times and sold shares on 22 occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in Edwards Lifesciences anymore.
Avg closing price
Price range
Sold -40.5 Thousand shares
Q3 2023
Avg closing price
$80.36
Price range
$69.28
-
$93.38
Increased shares by 45.5% (+12.7 Thousand shares)
Q2 2023
Avg closing price
$86.92
Price range
$81.41
-
$94.33
Sold 0.8% shares (-215 shares)
Q1 2023
Avg closing price
$78.60
Price range
$74.27
-
$84.51
New holding (+28.1 Thousand shares)
Q4 2022
Avg closing price
$77.07
Price range
$68.54
-
$87.44
Sold -38.1 Thousand shares
Q3 2022
Avg closing price
$96.22
Price range
$82.37
-
$107.29
Sold 0.7% shares (-277 shares)
Q2 2022
Avg closing price
$103.52
Price range
$86.50
-
$128.27
Increased shares by 0.7% (+261 shares)
Q1 2022
Avg closing price
$112.18
Price range
$101.96
-
$128.34
Increased shares by 9.2% (+3.22 Thousand shares)
Q4 2021
Avg closing price
$116.64
Price range
$106.37
-
$130.68
Sold 0.1% shares (-52 shares)
Q3 2021
Avg closing price
$114.14
Price range
$102.91
-
$122.75
Increased shares by 11.5% (+3.6 Thousand shares)
Q2 2021
Avg closing price
$94.26
Price range
$83.84
-
$104.76
Increased shares by 2.1% (+659 shares)
Q1 2021
Avg closing price
$84.54
Price range
$78.68
-
$90.67
New holding (+30.7 Thousand shares)
Q4 2020
Avg closing price
$82.95
Price range
$71.69
-
$91.23
Sold -34 Thousand shares
Q3 2020
Avg closing price
$78.03
Price range
$67.19
-
$87.44
Increased shares by 11.3% (+3.45 Thousand shares)
Q2 2020
Avg closing price
$71.07
Price range
$57.54
-
$76.95
Sold 40.0% shares (-20.4 Thousand shares)
Q1 2020
Avg closing price
$72.12
Price range
$52.41
-
$81.00
New holding (+50.9 Thousand shares)
Q4 2019
Avg closing price
$78.09
Price range
$71.70
-
$82.09
Sold -46 Thousand shares
Q3 2019
Avg closing price
$70.25
Price range
$61.55
-
$75.43
Sold 6.0% shares (-2.92 Thousand shares)
Q2 2019
Avg closing price
$60.47
Price range
$55.74
-
$64.41
Increased shares by 31.2% (+11.6 Thousand shares)
Q1 2019